As of June 21, 2025, Hexo Corp (HEXO.TO) reports a Net Margin of -558.65%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Hexo Corp's Net Margin
Over recent years, Hexo Corp's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2022-07-31 | -558.65% |
| 2021-07-31 | -92.62% |
| 2020-07-31 | -676.52% |
| 2019-07-31 | -146.42% |
| 2018-07-31 | -473.63% |
This slight downward trend highlights how Hexo Corp manages its overall profitability and cost control over time.
Comparing Hexo Corp's Net Margin to Peers
To better understand Hexo Corp's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Hexo Corp (HEXO.TO) | -558.65% |
| BioDelivery Sciences International Inc (BDSI) | 50.90% |
| Liberty Health Sciences Inc (LHS.CN) | 44.47% |
| SIGA Technologies Inc (SIGA) | 42.69% |
| Lotus Pharmaceuticals Inc (LTUS) | 19.84% |
| Knight Therapeutics Inc (GUD.TO) | 1.17% |
Compared to its competitors, Hexo Corp's Net Margin is among the lowest compared to peers, which may indicate challenges in controlling expenses or competitive pricing pressures.